Semin Respir Crit Care Med 2017; 38(04): 532-537
DOI: 10.1055/s-0037-1603768
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Sarcoidosis: Drugs under Investigation

Jonas Christian Schupp1, 2, Björn Christian Frye1, Gernot Zissel1, Joachim Müller-Quernheim1
  • 1Department of Pneumology, Medical Center - University of Freiburg, Medical Faculty, University of Freiburg, Germany
  • 2Section of Pulmonary, Critical Care and Sleep Medicine, Yale University School of Medicine, New Haven, Connecticut
Further Information

Publication History

Publication Date:
27 July 2017 (online)


Etiology of sarcoidosis is still elusive, yet there has been considerable progress in various areas of basic and clinical research. In this review, we focus on ongoing or recently completed clinical–pharmacological studies in patients with sarcoidosis. Positive studies were published in well-characterized and homogenous subcohorts of sarcoid patients. Several drugs have shown a positive effect on sarcoidosis-associated fatigue, cutaneous sarcoidosis, and pulmonary hypertension in sarcoid patients. It seems that the recruitment of clinically precisely defined subcohorts is necessary to achieve positive outcomes in studies on sarcoidosis.